Skip to main content

Novel Rx

      Interim analysis of the RELIANCE registry studying effect of canakinumab (CAN) in 80 patients w/ febrile CAPS. Efficacy
      4 years ago

      Interim analysis of the RELIANCE registry studying effect of canakinumab (CAN) in 80 patients w/ febrile CAPS. Efficacy of CAN assessed w/ AIDA (inflam index) showing ~70% were in low activity (<9) @ACR20 Abstr#1479 https://t.co/UC2eJbpVLM https://t.co/M71s8gXZY9

      Potpourri of Pathotypes of Predictors with RA Faculty

      Dr. Jonathan Kay again leads an international panel of rheumatologists to elicit their opinions on key abstracts at ACR 2020. Panelists: Dr. David Liew, Dr. Eric Dein, Dr. Meral El Ramahi, Dr. Richard Conway, Dr. Sheila Reyes and Dr. Jeffrey Sparks.

      Study of 351 SLE patients from Leiden shows that SLE with Neuropsychatric disease do not have a higher mortality than lu
      4 years ago
      Study of 351 SLE patients from Leiden shows that SLE with Neuropsychatric disease do not have a higher mortality than lupus without CNS disease; but do have higher mortality than gen. population #ACR20 Abstr#1264 https://t.co/CmBjfUj1Ur https://t.co/WYZQDaI4yt
      RT @KDAO2011: ACR/AF JIA guidelines presented @ACR20:
      👉Initiate DMARD early over NSAID monotherapy
      👉Use SQ MTX&gt
      4 years ago
      ACR/AF JIA guidelines presented @ACR20: 👉Initiate DMARD early over NSAID monotherapy 👉Use SQ MTX> oral MTX > SSZ/LEF 👉add biologic preferred over triple DMARD 👉DON'T use chronic low dose steroids 👉combo biologic+DMARD > biologic monoRx https://t.co/lwoFSTuV91 @rheumnow https://t.co/wzh2LCS0dN
      Pegloticase in Severe Refractory Gout: Dr. Olga Petryna

      Dr. Petryna reviews several pegloticase-related abstracts presented at the ACR 2020 annual meeting, including abstracts #0683 and #0677

      RT @ejdein1: Trivia from John Stone's pearls talk: Which is the biggest risk factor for disease flare in GCA? (All are s
      4 years ago
      Trivia from John Stone's pearls talk: Which is the biggest risk factor for disease flare in GCA? (All are statistically signif RFs). #ACR20 @RheumNow
      RT @ejdein1: John Stone: "The HISTORY is the Rheumatologist's scalpel." TA bx is not gold standard in diagnosis, as not
      4 years ago
      John Stone: "The HISTORY is the Rheumatologist's scalpel." TA bx is not gold standard in diagnosis, as not fully sensitive. @RheumNow #ACR20.
      RT @drdavidliew: Abatacept in IgG4-RD. Plausible, but does it work?

      Pilot n=10 @MGHrheumatology
      ABA +&lt;4w PNL

      Some h
      4 years ago
      Abatacept in IgG4-RD. Plausible, but does it work? Pilot n=10 @MGHrheumatology ABA +<4w PNL Some hit, some miss - but mechanistic correlates of response: Tfh2, unswitched memory B cells. Exploring new options (w real benefit) very welcome in IgG4-RD! #ACR20 ABST1480 @RheumNow https://t.co/0saS941Lga
      RT @KDAO2011: #ACR20 Dr. M. Crow on Lupus #StateofArtLecture reviews treatment of SLE:
      1. HCQ is the foundation of Rx
      2
      4 years ago
      #ACR20 Dr. M. Crow on Lupus #StateofArtLecture reviews treatment of SLE: 1. HCQ is the foundation of Rx 2. keep pred <7.5mg/day 3. belimumab works better when given early in disease (<2 yrs) 4. combination Rx may be needed @rheumnow https://t.co/6zh1xkLXgN